TORONTO - Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.

Earlier this week, I posted a question on social media. It went something like this, “Without sarcasm, political insults or ...

One of the highest yields you can get right now is from Pfizer ( PFE 0.90%). The healthcare giant offers a yield of 6.8%, ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

KIRKLAND, QC, March 17, 2025 /CNW/ - Pfizer Canada is pleased to announce that IXIFI ® (infliximab for injection) will be available in Canada as of April 1. IXIFI ® is a biosimilar to Remicade ...

This World Cancer Day, Pfizer Canada ULC, together with Rethink Breast Cancer, Colorectal Cancer Canada, Lung Health Foundation, Lung Cancer Canada, and the Quebec Lung Association, is pleased to ...

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.

Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized the KP.2 variant adapted COMIRNATY® COVID-19 vaccine for ages 6 months and older ...

Health Canada recently asked provinces and territories to get rid of their older COVID-19 vaccines to ensure the most current vaccine will be used during this fall's respiratory virus season.

Health Canada approved Pfizer-BioNTech's updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of ...